EPISODE · Aug 31, 2026 · 12 MIN
今天3分钟我们来聊聊黄金22天：突发耳聋后这个时间窗内治疗可能恢复听力
from 源于细胞BioInsid的个人播客
本期源于细胞科普突发性耳聋相关知识，详解国内最新脐带干细胞外泌体鼓室注射I期临床试验，揭秘其安全性与初步疗效，探讨该疗法未来的临床应用潜力与待解问题。 📚 参考文献： Zhang H, et al. Intratympanic injection of human umbilical cord mesenchymal stem cell derived small extracellular vesicles for refractory sudden sensorineural hearing loss: a Phase 1 trial. Stem Cell Research & Therapy, 2026-06-30. 临床试验注册号：ChiCTR2500103765 关键数据：13例入组/12例完成8周随访；4剂量组（8×10⁸至1×10¹¹颗粒/mL）；连续5天鼓室注射；5/12（42%）PTA改善≥15dB；低剂量组（C/D组）应答率最高；所有应答者病程≤22天；无严重不良事件 前往小宇宙评论区与主播互动
Embed this episode
Ready to play
今天3分钟我们来聊聊黄金22天：突发耳聋后这个时间窗内治疗可能恢复听力
0:00
12:00
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
Frequently Asked Questions
How long is this episode of 源于细胞BioInsid的个人播客?
This episode is 12 minutes long.
When was this 源于细胞BioInsid的个人播客 episode published?
This episode was published on August 31, 2026.
Can I download this 源于细胞BioInsid的个人播客 episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!